Synergy Pharmaceuticals – Seeks Approval of KEIP for CEO and CFO, Maximum Payment of $2.08mn if Auction Generates $600mn

December 31, 2018 – Synergy Pharmaceuticals has filed a motion seeking approval of a key employee incentive plan (the “KEIP”) for the Debtors’ Chief Executive Officer and Chief Financial Officer [Docket No. 142].   The KEIP motion states, “As the Debtors implement the process for the sale of substantially all of their assets (the ‘Sale’),…